GCC Diagnostic

Global teams co-create solutions with the GCC in working sessions, not just review GCC deliverables.

GCC leaders are invited to global strategy discussions before decisions are made—not briefed after.

When problems arise, global stakeholders ask the GCC for perspective on what to do—not just how to execute.

The GCC is measured on business impact (e.g., "accelerated launch by 2 weeks") not output volume ("delivered 50 reports").

When targets are missed, the GCC owns the outcome and fixes it—rather than citing "unclear requirements from global."

GCC teams can challenge stakeholder requests and propose better approaches without damaging the relationship.

GCC team members are recognized as domain experts in pharma commercial operations—not just skilled at following SOPs.

The GCC has autonomy to redesign processes and workflows without seeking approval for every change.

Senior leaders cite the GCC's specialized capabilities as a competitive advantage to external stakeholders.

High performers can see a credible path to the next level (promotion, new skill, global role) without leaving the GCC.

We successfully recruit senior talent (15+ years) from top consulting firms, Big Tech, or global pharma HQs.

Our voluntary attrition rate is lower than the industry average for healthcare GCCs.